# clm_0D057E1B2379

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: cfo  
value: Christopher Fenimore  
valid_from: 2024-02-01  
valid_to: null  
published: 2026-04-24  
recorded: 2026-11-08  
confidence: 0.95  
status: valid  
assertable: true  
superseded_by: null  
last_updated: 2026-11-09  
cite: AsOf. "Regeneron Pharmaceuticals cfo: Christopher Fenimore", as of 2024-02-01. Claim clm_0D057E1B2379, https://asof.is/claim/clm_0D057E1B2379, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm.  
checked: 2026-11-09 · its source page states the value and the date  

> Effective February 2024, the board appointed Christopher Fenimore to succeed Robert E. Landry as the Company’s Chief Financial Officer upon Mr. Landry’s retirement.

What https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm says, word for word.

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000130817926000340/regn-20260424.htm (primary, SEC EDGAR DEF 14A, published 2026-04-24)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.